Neural Regeneration Research

Article	Citations
Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them	282
Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation	250
SCFD1 in amyotrophic lateral sclerosis: reconciling a genetic association with in vivo functional analysis	163
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	111
Contribution of adult-born neurons to memory consolidation during rapid eye movement sleep	104
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	95
LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities	83
The delivery of miR-21a-5p by extracellular vesicles induces microglial polarization via the STAT3 pathway following hypoxia-ischemia in neonatal mice	81
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	74
Functions of nuclear factor Y in nervous system development, function and health	63
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	62
The role of miRNA in retinal ganglion cell health and disease	58
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases	53
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease	52
Stepping up after spinal cord injury: negotiating an obstacle during walking	50
Transcription factors promote neural regeneration after spinal cord injury	49
Axonal protein synthesis in central nervous system regeneration: is building an axon a local matter?	48
Eph receptor A4 regulates motor neuron ferroptosis in spinal cord ischemia/reperfusion injury in rats	48
Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?	47
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	46
NECAB family of neuronal calcium-binding proteins in health and disease	46
Protocadherin gamma C3: a new player in regulating vascular barrier function	46
Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway	46
Chronic traumatic encephalopathy: genes load the gun and repeated concussion pulls the trigger	44
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons	44

Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis	44
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	43
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	43
Neuromodulation techniques for modulating cognitive function: enhancing stimulation precision and intervention effects	43
Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: targeting brain metabolic and vascular restoration	42
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	42
Chx10+V2a interneurons in spinal motor regulation and spinal cord injury	42
Increased activation of the caudate nucleus and parahippocampal gyrus in Parkinson’s disease patients with dysphagia after repetitive transcranial magnetic stimulation: a case-control study	41
Retraction: Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy	41
Role of copper chelating agents: between old applications and new perspectives in neuroscience	41
Decoding molecular mechanisms: brain aging and Alzheimer’s disease	40
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke	40
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway	40
Could inorganic polyphosphate be a valid target against neuronal senescence?	39
Neurogenesis dynamics in the olfactory bulb: deciphering circuitry organization, function, and adaptive plasticity	39
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury	39
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders	37
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target	37
Functional near-infrared spectroscopy in non-invasive neuromodulation	37
Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress	37
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders	37
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	36
Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease	36
Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease	35
Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury	35
Necrostatin-1 decreases necroptosis and inflammatory markers after intraventricular hemorrhage in mice	35
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease	35
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	34
Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury	34
Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury	34
Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases	34
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	33
The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases	33
The power of “touch” and early enriched stimulation: neuroplasticity effects in rodents and preterm infants	33
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	32
Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events: a prospective observational study	32
Amyloid-beta and tau protein beyond Alzheimer’s disease	32
Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes	32
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	31
Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis	31
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy	31
Glymphatic imaging and modulation of the optic nerve	31
GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries	31
Commentary on “PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons”	30
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury	30
Extracellular vesicles: multiple signaling capabilities and translation into promising therapeutic targets to promote neuronal plasticity	30
Blocking postsynaptic density-93 binding to C-X3-C motif chemokine ligand 1 promotes microglial phenotypic transformation during acute ischemic stroke	30
Crosstalk among canonical Wnt and Hippo pathway members in skeletal muscle and at the neuromuscular junction	30
Utility of droplet digital polymerase chain reaction for studying somatic mosaicism: brain malformations and beyond	29
Brain ischemia as a bridge to Alzheimer’s disease	29

Insights from an academic endeavor into central nervous system drug discovery	29
New aspects of a small GTPase RAB35 in brain development and function	29
Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease	29
Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington's disease	29
Unraveling the role of ufmylation in the brain	28
Optical tissue clearing enables rapid, precise and comprehensive assessment of three-dimensional morphology in experimental nerve regeneration research	28
Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis	28
Optogenetics stimulates nerve reorganization in the contralesional anterolateral primary motor cortex in a mouse model of ischemic stroke	28
NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression	27
Exploration of C-terminal CX3CL1 for reducing age-dependent neurodegeneration	27
Endorepellin downregulation promotes angiogenesis after experimental traumatic brain injury	27
Premature axon-oligodendrocyte interaction contributes to stalling of experimental axon regeneration after injury to the white matter	27
Amyotrophic lateral sclerosis disease burden: doing better at getting better	27
A Drosophila perspective on retina functions and dysfunctions	27
Neuron-fibrous scaffold interfaces in the peripheral nervous system: a perspective on the structural requirements	26
Effects of C2 hemisection on respiratory and cardiovascular functions in rats	26
The secondary injury cascade after spinal cord injury: an analysis of local cytokine/chemokine regulation	26
Cell senescence, loss of splicing, and lipid metabolism in TDP-43-related neurodegenerative processes	26
Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson′s disease	26
Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma	26
Argatroban promotes recovery of spinal cord injury by inhibiting the PAR1/JAK2/STAT3 signaling pathway	26
Effects of electroacupuncture on the functionality of NG2-expressing cells in perilesional brain tissue of mice following ischemic stroke	25
Status of precision medicine approaches to traumatic brain injury	25
Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesions	25
microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury	25
New insights into the role of the endoplasmic reticulum in microglia	25
Targeting muscle to treat Charcot-Marie-Tooth disease	25
Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery	25
NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer’s disease	25
Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease	25
On the functions of astrocyte-mediated neuronal slow inward currents	24
Retraction: Ultrasound guided neural stem cell transplantation through the lateral ventricle for treatment of cerebral palsy in children	24
Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury	24
New insights on the role of chondroitin sulfate proteoglycans in neural stem cell–mediated repair in spinal cord injury	24
Exploring the novel role of oligodendrocyte precursor cells in phagocytosis: beyond myelinogenesis	24
Post-acute ischemic stroke hyperglycemia aggravates destruction of the blood-brain barrier	24
Dysfunction of synaptic endocytic trafficking in Parkinson’s disease	24
Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury	24
Modulation of p75 neurotrophin receptor mitigates brain damage following ischemic stroke in mice	24
Biochanin A attenuates spinal cord injury in rats during early stages by inhibiting oxidative stress and inflammasome activation	24
Therapeutic effects of low-intensity transcranial focused ultrasound stimulation on ischemic stroke in rats: an in vivo evaluation using electrical impedance tomography	24
Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury	23
Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis	23
Prediction of cell-cell communication patterns of dorsal root ganglion cells: single-cell RNA sequencing data analysis	23
A core scientific problem in the treatment of central nervous system diseases: newborn neurons	23
Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease	23
Advances in non-invasive imaging of proteinopathies in animal models of neurodegenerative diseases	23
Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease	23
Converging assemblies: a putative building block for brain function and for interfacing with the brain	22
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease	22
Ruxolitinib attenuates secondary injury after traumatic spinal cord injury	22
Transcranial photobiomodulation for the brain: a wide range of clinical applications	22
Small extracellular vesicles derived from cerebral endothelial cells with elevated microRNA 27a promote ischemic stroke recovery	22
The neuroprotective effects of oxygen therapy in Alzheimer’s disease: a narrative review	22
Blood-brain barrier pathology in cerebral small vessel disease	22
Neural and Müller glial adaptation of the retina to photoreceptor degeneration	22
Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?	22
M2 macrophages mediate fibrotic scar formation in the early stages after cerebral ischemia in rats	22
The critical role of the endolysosomal system in cerebral ischemia	22
Role of microtubule dynamics in Wallerian degeneration and nerve regeneration after peripheral nerve injury	22
Implication of gut microbiome in age-related macular degeneration	21
Magnesium-L-threonate treats Alzheimer’s disease by modulating the microbiota-gut-brain axis	21
Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis	21
The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease	21
Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming	21
Biomaterial-based strategies: a new era in spinal cord injury treatment	21
Semaphorin7A: its role in the control of serotonergic circuits and functional recovery following spinal cord injury	21
Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degeneration	21
Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy	21
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders	21
Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury	21
Heterogeneity of mature oligodendrocytes in the central nervous system	21
Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation	21
Neuronal autosis: the self-destructive side of autophagy involved in hypoxic-ischemic neuronal death	20
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	20
Data and subject heterogeneity and data sharing: keys to translational success in spinal cord injury research?	20
Artificial nerve graft constructed by coculture of activated Schwann cells and human hair keratin for repair of peripheral nerve defects	20
Neuronal chemokines: new insights into neuronal communication after injury	20
Making bridges between preclinical and clinical insights into age-related cognitive decline	20
Delayed activation of leg somatotopic fibers of an injured corticospinal tract in a patient with cerebral infarction	20

Carboplatin restores neuronal toxicity in FUS-linked amyotrophic lateral sclerosis	20
Schwann cell extracellular vesicles: judging a book by its cover	20
Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury	20
Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease	20
Two become one: combination of two risk factors in a new glaucoma animal model	20
Graphene oxide-composited chitosan scaffold contributes to functional recovery of injured spinal cord in rats	20
Bioactive material promotes long-distance regeneration of optic nerve to restore visual functions	20
5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis	19
Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer’s disease	19
Current progress of mitochondrial therapy for neural regeneration	19
Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson’s disease	19
Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, n	19
Metformin remodels the myelin landscape	19
Profile of the RNA in exosomes from astrocytes and microglia using deep sequencing: implications for neurodegeneration mechanisms	19
Matrin-3 dysfunction in myopathy and motor neuron degeneration	19
Clues from a missense mutation of the adenosine A1 receptor gene associated with early-onset Parkinson’s disease	19
Knockout of Sirt2 alleviates traumatic brain injury in mice	19
Effects of delayed repair of peripheral nerve injury on the spatial distribution of motor endplates in target muscle	19
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles	19
Stiffness-tunable biomaterials provide a good extracellular matrix environment for axon growth and regeneration	19
Interconnections between diabetic corneal neuropathy and diabetic retinopathy: diagnostic and therapeutic implications	19
Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina	19
Mechanosensitive Piezo1 channel regulation of microglial cell function and implications to neurodegenerative diseases and neuroinflammation	19
Complement activation kindles the transition of acute post-traumatic brain injury to a chronic inflammatory disease	19
Effects of quercetin and its derivatives in in vivo models of neuroinflammation: a systematic review and meta-analysis	19
Transcranial electrical stimulation in neurological disease	19
Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?	19
Tau’s function and dysfunction in the brain	19
Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database	19
Multiple sclerosis drug repurposing for neuroregeneration	19
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease	18
Inhibitory gamma-aminobutyric acidergic neurons in the anterior cingulate cortex participate in the comorbidity of pain and emotion	18
Exploring the synergy of the eye-brain connection: neuromodulation approaches for neurodegenerative disorders through transcorneal electrical stimulation	18
Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration	18
How mind-body therapies might reduce pathological features of Alzheimer’s disease	18
Neuroinflammation revisited through the microglial lens	18
Letter from the Editor-in-Chief	18
Brain-derived cell-free DNA	18
Secretory autophagy in neurons: more than throwing out the trash?	18
Sex differences in Alzheimer’s disease: an urgent research venue to follow	18
Unexpected role of complement component 8 gamma chain in the inflamed brain	18
Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?	18
Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapy	18
Actin(g) toward a revised understanding of the role of cytoskeletal dynamics in neuronal bioenergetics	18
Neuronal plasticity and its role in Alzheimer’s disease and Parkinson’s disease	18
Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease	18
Fibrinogen’s potential role in connecting cerebrovascular abnormalities with glymphatic dysfunction in Alzheimer’s disease	18
Renin-angiotensin system in the central nervous system: focus on Huntington’s disease	18
Low-density lipoprotein receptor-related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease	18
Extracellular vesicles for neural regeneration after spinal cord injury	17
PANoptosis: new insights in regulated cell death in ischemia/reperfusion models	17
The new wave of p75 neurotrophin receptor targeted therapies	17
Gut microbiota neurotransmitters: influence on risk and outcome of ischemic stroke	17
Stable isotope labeling-mass spectrometry as a new approach to determine remyelination	17
Activity-dependent remodeling of genome architecture in engram cells facilitates memory formation and recall	17
Transplantation of human neural stem cells repairs neural circuits and restores neurological function in the stroke-injured brain	17
Optogenetic neuroregeneration	17
Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies	17
Neuron-neuron attraction shapes morphology and activity of tissue engineered brain constructs	17
Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease	17
High-dose biotin neither fosters remyelination nor stimulates malonyl coenzyme A synthesis in the regenerating nerve	17
A novel viewpoint in glaucoma therapeutics: enriched environment	17
MET receptor tyrosine kinase promotes the generation of functional synapses in adult cortical circuits	17
C–C motif chemokine ligand 2/C–C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury	17
Accelerating peripheral nerve regeneration using electrical stimulation of selected power spectral densities	17
Magnetic resonance imaging focused on the ferritin heavy chain 1 reporter gene detects neuronal differentiation in stem cells	17
Remaking a connection: molecular players involved in post-injury synapse formation	17
Deuterated dextromethorphan/quinidine for agitation in Alzheimer’s disease	17
Strategies to treat neurodegeneration in neuronal ceroid lipofuscinosis: a view onto the retina	17
Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?	17
(D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer’s disease transgenic mice	17
Targeting autophagy by polyphenols to prevent glycative stress-toxicity in the brain	17
How physical and motor training affect cognitive performance: lessons from an inflammatory molecule	16
Ferroptosis mechanism and Alzheimer's disease	16
Ischemic accumulation of succinate induces Cdc42 succinylation and inhibits neural stem cell proliferation after cerebral ischemia/reperfusion	16
Iron-handling solute carrier SLC22A17 as a blood–brain barrier target after stroke	16
Pathophysiological changes of muscle after ischemic stroke: a secondary consequence of stroke injury	16
Beyond wrecking a wall: revisiting the concept of blood–brain barrier breakdown in ischemic stroke	16
Taurine: a promising nutraceutic in the prevention of retinal degeneration	16
Intranasal nerve growth factor for prevention and recovery of the outcomes of traumatic brain injury	16
Striatum-specific mechanisms regulate neuronal cell cycle re-entry: the choice between life and death	16
Combined cell-based therapy strategies for the treatment of Parkinson’s disease: focus on mesenchymal stromal cells	16
Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure	16
Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies	16
Correlations between hippocampal functional connectivity, structural changes, and clinical data in patients with relapsing-remitting multiple sclerosis: a case-control study using multimodal magnetic	16
Electroacupuncture treatment improves motor function and neurological outcomes after cerebral ischemia/reperfusion injury	16
A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration	16
Astrocyte evolution and human specificity	16
Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models	16
Mitochondrial therapeutics and mitochondrial transfer for neurodegenerative diseases and aging	16
Estrogen rapid effects: a window of opportunity for the aging brain?	16
Circulating extracellular vesicles: friends and foes in neurodegeneration	16
From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson’s disease?	16
M1-type microglia can induce astrocytes to deposit chondroitin sulfate proteoglycan after spinal cord injury	16
Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury	16